TURP is useful for diagnosing early stage prostate cancer

URO TODAY: Benign prostatic hyperplasia patients in whom prostate cancer is suspected and who have urination problems, with a previously negative biopsy result, can undergo transurethral resection of the prostate, which treats bladder outlet obstruction and gives early diagnosis of prostate cancer. READ MORE>

Read Full Post »

Combo drug for prostatic hyperplasia in men with enlarged prostate

PHARMA TIMES: US regulators have approved GlaxoSmithKline’s combination drug, Jalyn, to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate. READ MORE>

Read Full Post »

PERSONAL STORY: When prostate rules it’s not OK

---

DOMINION POST: In this personal account, a Lower Hutt man recalls the dire effects on his life of an enlarged prostate – and how he finally got it fixed.

When prostate rules it’s not OK

…was too late. I was in trouble again – this time on an island miles from a hospital. I returned in some discomfort to the company and tried to act as if everything was OK. We left soon after. When we got to the cottage I sat on the toilet until I got…read more…

Read Full Post »

New drug for treating benign prostatic hyperplasia enters phase 2 clinical trial in US

BIO-MEDICINE: The first patients have entered a Phase 2 clinical trial of a innovative targeted drug treatment, Aptocine(TM) (talaporfin sodium), for benign prostatic hyperplasia (enlarged prostate). READ MORE>

Read Full Post »

PROSTATE RESEARCH: Surgery for benign enlarged prostate doesn’t eliminate cancer risk

JUNE 20: URO TODAY: Men undergoing surgical interventions for benign enlarged prostate are still at risk for subsequent development of prostate cancer due to residual tissue. READ MORE>

Read Full Post »

PROSTATE EXAMS: Doctor writes about wierd way he was taught to do digital exams

MAY 26:  TALES FROM SERENITY NOW HOSPITAL:  How some (semi-literate) US doctors learn to perform digital examinations on patients – a bizarre tale:  “The patient (sic) recieved 100 dollars per five rectals or 20 bucks each finger. Many of these patients smelled of alcohol, had no teeth, had mental illnesses, and were addicted to IV drugs…” READ MORE>

Read Full Post »

PROSTATE RESEARCH: Drug used for enlarged prostate also reduces cancer risk

BIO-MEDICINE: Dutasteride (Avodart), a commonly prescribed drug to treat benign prostatic hyperplasia, has been shown to lower the risk of prostate cancer by 23 percent in men with an increased risk of the disease, according to results of an international clinical trial presented yesterday at the American Urological Association annual meeting in Chicago. READ MORE>

Read Full Post »